Ausgabe 2/2017
Inhalt (26 Artikel)
Is there a role for sentinel node biopsy in the pre-operative ultrasound positive axilla?
M. Ahmed, F. Jozsa, M. Douek
Predictors of distress in female breast cancer survivors: a systematic review
Ania Syrowatka, Aude Motulsky, Siyana Kurteva, James A. Hanley, William G. Dixon, Ari N. Meguerditchian, Robyn Tamblyn
Breast cancer oral anti-cancer medication adherence: a systematic review of psychosocial motivators and barriers
Cheryl Lin, Rachel Clark, Pikuei Tu, Hayden B. Bosworth, Leah L. Zullig
Breast cancer electron intraoperative radiotherapy: assessment of preoperative selection factors from a retrospective analysis of 758 patients and review of literature
S. Takanen, A. Gambirasio, G. Gritti, M. Källi, S. Andreoli, M. Fortunato, L. Feltre, F. R. Filippone, E. Iannacone, L. Maffioletti, R. Muni, F. Piccoli, E. M. P. Mauri, A. Paludetti, M. Giovanelli, L. Burgoa, C. Valerii, F. Palamara, M. Ferro, P. Fenaroli, C. A. Tondini, L. F. Cazzaniga
Meta-analysis of pre-operative magnetic resonance imaging (MRI) and surgical treatment for breast cancer
Nehmat Houssami, Robin M. Turner, Monica Morrow
Reassessing risk models for atypical hyperplasia: age may not matter
Emanuele Mazzola, Suzanne B. Coopey, Molly Griffin, Fernanda Polubriaginof, Julliette M. Buckley, Giovanni Parmigiani, Judy E. Garber, Barbara L. Smith, Michele A. Gadd, Michelle C. Specht, Anthony Guidi, Kevin S. Hughes
Subtype-specific prognostic impact of different immune signatures in node-negative breast cancer
A.-S. Heimes, K. Madjar, K. Edlund, M. J. Battista, K. Almstedt, T. Elger, S. Krajnak, J. Rahnenführer, W. Brenner, A. Hasenburg, J. G. Hengstler, M. Schmidt
The financial impact and drivers of hospital charges in contralateral prophylactic mastectomy and reconstruction: a Nationwide Inpatient Sample hospital analysis
Alexandra Bucknor, Anmol Chattha, Klaas Ultee, Winona Wu, Parisa Kamali, Patrick Bletsis, Austin Chen, Bernard T. Lee, Claire Cronin, Samuel J. Lin
Survival improvement in hormone-responsive young breast cancer patients with endocrine therapy
Tae In Yoon, Ui-Kang Hwang, Eui Tae Kim, SaeByul Lee, Guiyun Sohn, Beom Seok Ko, Jong Won Lee, Byung Ho Son, Seonok Kim, Sei Hyun Ahn, Hee Jeong Kim
The efficacy of lymphaticovenular anastomosis in breast cancer-related lymphedema
H. Winters, H. J. P. Tielemans, M. Hameeteman, V. A. A. Paulus, C. H. Beurskens, N. J. Slater, D. J. O. Ulrich
Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial
Javier Cortés, Hope S. Rugo, Ahmad Awada, Chris Twelves, Edith A. Perez, Seock–Ah Im, Patricia Gómez-Pardo, Lee S. Schwartzberg, Veronique Diéras, Denise A. Yardley, David A. Potter, Audrey Mailliez, Alvaro Moreno-Aspitia, Jin-Seok Ahn, Carol Zhao, Ute Hoch, Mary Tagliaferri, Alison L. Hannah, Joyce O’Shaughnessy
IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients
Carlo Palmieri, Rob C. Stein, Xinxue Liu, Emma Hudson, Hanna Nicholas, Hironobu Sasano, Fouzia Guestini, Chris Holcombe, Sophie Barrett, Laura Kenny, Sadie Reed, Adrian Lim, Larry Hayward, Sacha Howell, R. Charles Coombes
Development of a Ki-67-based clinical trial assay for neoadjuvant endocrine therapy response monitoring in breast cancer
Rodrigo Goncalves, Katherine DeSchryver, Cynthia Ma, Yu Tao, Jeremy Hoog, Maggie Cheang, Erika Crouch, Neha Dahiya, Souzan Sanati, Michael Barnes, Luis Otávio Zanatta Sarian, John Olson, Donald Craig Allred, Matthew J. Ellis
Antitumor activity and safety profile of weekly carboplatin plus paclitaxel in metastatic breast cancer: a ten-year, monocentric, retrospective study
Claudio Vernieri, Monica Milano, Alessia Mennitto, Claudia Maggi, Benvenuto Ferrari, Lucia Rinaldi, Roberta Mennitto, Claudia Stefanetti, Barbara Re, Gabriella Mariani, Giulia Bianchi, Giuseppe Capri, Filippo de Braud
A Phase I/II study of suberoylanilide hydroxamic acid (SAHA) in combination with trastuzumab (Herceptin) in patients with advanced metastatic and/or local chest wall recurrent HER2-amplified breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1104)
Lori J. Goldstein, Fengmin Zhao, Molin Wang, Ramona F. Swaby, Joseph A. Sparano, Neal J. Meropol, Kapil N. Bhalla, Christine M. Pellegrino, R. Katherine Alpaugh, Carla I. Falkson, Paula Klein, George W. Sledge
COX2 induction: a mechanism of endocrine breast cancer resistance?
Brandi L. Clark, Michael A. Murphy, Landry K. Kamdem
The prognostic effect of estrogen receptor status differs for younger versus older breast cancer patients
Victoria Sopik, Ping Sun, Steven A. Narod
Incidence and treatments of DCIS in octogenarians: grade matters
Erin P. Ward, Anna Weiss, Sarah L. Blair
Pleomorphic lobular carcinoma in situ of the breast: a single institution experience with clinical follow-up and centralized pathology review
Marina De Brot, Starr Koslow Mautner, Shirin Muhsen, Victor P. Andrade, Anita Mamtani, Melissa Murray, Dilip Giri, Rita A. Sakr, Edi Brogi, Tari A. King
Interaction of mammographic breast density with menopausal status and postmenopausal hormone use in relation to the risk of aggressive breast cancer subtypes
Lusine Yaghjyan, Rulla M. Tamimi, Kimberly A. Bertrand, Christopher G. Scott, Matthew R. Jensen, V. Shane Pankratz, Kathy Brandt, Daniel Visscher, Aaron Norman, Fergus Couch, John Shepherd, Bo Fan, Yunn-Yi Chen, Lin Ma, Andrew H. Beck, Steven R. Cummings, Karla Kerlikowske, Celine M. Vachon
Preferences for breast cancer risk reduction among BRCA1/BRCA2 mutation carriers: a discrete-choice experiment
Alexander Liede, Carol A. Mansfield, Kelly A. Metcalfe, Melanie A. Price, Carrie Snyder, Henry T. Lynch, Sue Friedman, Justyna Amelio, Joshua Posner, Steven A. Narod, Geoffrey J. Lindeman, D. Gareth Evans
Utilization of hypofractionated whole-breast radiation therapy in patients receiving chemotherapy: a National Cancer Database analysis
Tejan P. Diwanji, Jason K. Molitoris, Arpit M. Chhabra, James W. Snider, Soren M. Bentzen, Katherine H. Tkaczuk, Paula Y. Rosenblatt, Susan B. Kesmodel, Emily C. Bellavance, Randi J. Cohen, Sally B. Cheston, Elizabeth M. Nichols, Steven J. Feigenberg
Opioid use among female breast cancer patients using different adjuvant endocrine therapy regimens
Xi Tan, Tareq Fabian Camacho, Virginia T. LeBaron, Leslie J. Blackhall, Rajesh Balkrishnan
Antibody-based therapies for the treatment of brain metastases from HER2-positive breast cancer: time to rethink the importance of the BBB?
Vasileios Askoxylakis, David P. Kodack, Gino B. Ferraro, Rakesh K. Jain
Erratum to: Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trial
Milagros González-Rivera, Miriam Lobo, Sara López-Tarruella, Yolanda Jerez, María del Monte-Millán, Tatiana Massarrah, Rocío Ramos-Medina, Inmaculada Ocaña, Antoni Picornell, Sonia Santillán Garzón, Lucía Pérez-Carbornero, José A. García-Saenz, Henry Gómez, Fernando Moreno, Iván Márquez-Rodas, Hugo Fuentes, Miguel Martin